secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xtant Medical Holdings, Inc. (XTNT)
CIK:        0001453593
Form:       8-K
Filed at:   2025-08-08T23:59:59+00:00
Accession:  0001641172-25-022762
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Xtant Medical sets Nov 7, 2025 for annual meeting; proposal deadline Aug 18, 2025
--------------------------------------------------------------------------------

- Annual meeting scheduled for November 7, 2025; proxy statement expected around September 12, 2025.
- Stockholder proposals for proxy inclusion under Rule 14a-8 must be received by August 18, 2025.
- Director nominations and other proposals (non-Rule 14a-8) also due by August 18, 2025.
- Universal proxy rule (Rule 14a-19) compliance deadline for nominees is September 8, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1453593/000164117225022762/0001641172-25-022762-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1453593/000164117225022762/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-022762

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer